TEL
AVIV, Israel, March 5,
2025 /PRNewswire/ -- Arbe Robotics Ltd. (NASDAQ:
ARBE) (TASE: ARBE) ("Arbe"), a global leader in Perception Radar
solutions, today announced financial results for its fourth quarter
and full year ended on December 31,
2024.
Q4 and Full Year 2024 Company Highlights:
Successful Capital Raise:
Arbe successfully completed fundraising initiatives aimed at
fortifying the company's financial position and providing long-term
stability, raising a total of approximately $70 million, through the following
transactions:
- $33 million raised through an
underwritten registered direct offering, which included the
exercise of a $4 million
over-allotment option by the underwriters, led by Canaccord
Genuity, which closed in January
2025.
- $21.5 million released to the
Company in January 2025 from the
escrow account following the conversion of convertible bonds issued
on the TASE in 2024.
- $15 million raised in an
underwritten public offering that closed in November 2024, led by Canaccord Genuity,
along with $0.5 million raised in
January 2025 from the exercise of
warrants issued as part of the November
2024 offering.
Customer Engagements:
- Arbe experienced significant increase in both the scale and
depth of our OEM (Original Equipment Manufacturer) engagements in
2024. The company is currently active with 15 OEMs, 11 of which
have advanced to the bid stage, and 8 have entered the advanced
perception project phase. Additionally, our RFI and RFQ
pipeline remains strong and is steadily expanding.
- Arbe's chipset was chosen by a top 10 global OEM to develop its
next-generation imaging radar.
- Zenseact, specializing in AI and software solutions, and Arbe's
tier 1 Sensrad have announced a joint exploration of 4D
high-resolution imaging radar to enhance safety in automated
driving.
- Arbe collaborated with a leading European truck manufacturer to
integrate its radar chipset into the manufacturer's self-driving
sensor suite.
- HiRain Technologies accelerated the development of an ADAS
system for a Chinese OEM, aiming to replace LiDAR with Arbe's radar
chipset.
- Sensrad signed a framework agreement to supply 4D imaging
radars, powered by Arbe's chipset, to Tianyi Transportation
Technology in China for
vehicle-road-cloud integration technology.
Collaborations:
- NVIDIA collaborated with Arbe to enhance radar-based free space
mapping and AI-driven capabilities, Arbe's high-resolution radar
integration with the NVIDIA DRIVE AGX in-vehicle computing platform
was showcased at CES 2025.
- Horizon Robotics, a premier provider of computing solutions for
ADAS and AD, presented the integration of Weifu's 4D Imaging
Radar, powered by Arbe's chipset, with Horizon's
Journey 6 Automotive AI processor, as part of their
ecosystem at the 2024 Beijing International Automotive
Exhibition.
Growing Potential Market Demand:
Arbe has experienced increasing interest in its radar technology
from leaders in the automotive industry, as well as from emerging
verticals beyond automotive, and is actively working with customers
to address these opportunities.
"We are excited about the progress we have made in product
development and the strong industry relationships we have built in
2024," said Kobi Marenko, Chief
Executive Officer. "It is now evident that hands-free, eyes-off
driving requires imaging radar capabilities that we believe only
Arbe and a select few other companies can provide. While the
decision-making process and development timelines have taken longer
than initially anticipated, we have not received negative responses
or missed any opportunities, and the total addressable market
continues to expand. Based on our current engagements and our
ability to secure and execute contracts with leading OEMs, we
estimate that by 2030, we should be able to ship approximately 5
million imaging radar chipsets to our customers.
"We are also encouraged by the strong investor confidence in
Arbe, demonstrated by our recent fundraising efforts, which raised
nearly $70 million. This funding
enhances our financial resilience, strengthens our ability to
execute on our growing RFI and RFQ pipeline, and solidifies our
competitive position. The continued support from investors,
including AWM Special Situations Fund, one of our largest
shareholders, which has now invested in Arbe's fundraising rounds
for the third time, reinforces confidence in our vision and
strategy. With an improved liquidity position and a clear path
forward, we believe we are accelerating our trajectory toward
profitability and are well positioned to drive broader adoption of
our radar technology in the automotive industry," concluded
Marenko.
Fourth Quarter and Full Year 2024 Financial
Highlights
Revenues for Q4 2024 were $0.1
million, compared to $0.35
million in Q4 2023. Full year 2024 revenues were
$0.8 million, a decrease from
$1.5 million in 2023. Backlog as of
December 31, 2024, represents
$0.3 million.
Gross margin loss in Q4 2024 was similar to the gross margin
loss in Q4 2023, at a level of $0.2
million. Q4 2024 gross margin loss resulted from low
quarterly revenue. Gross margin for the full year of 2024 was a
$0.8 million loss compared to a
$0 gross margin in 2023. Year over
year gross margin reduction is mainly related to the low level of
revenue and to the increase in labor cost.
Operating expenses in Q4 2024 were $12.6
million, compared to $11.9
million in Q4 2023. Operating expenses for the full year of
2024 were $48.9 million, compared to
$46.8 million in 2023. The increase
in operating expenses was primarily a result of non-cash
share-based compensation expense. Additionally, the increase in
production ramp up related costs, the doubtful debt provisions, and
to a lesser extent, the increase in labor cost, were offset by a
decrease in research and development due to the finalization of
costs related to our advanced production stage and the savings in
our D&O insurance.
Net loss in the fourth quarter of 2024 was $12.2 million compared to a net loss of
$9.3 million in the same period of
2023. Net loss for the full year of 2024 was $49.3 million compared to a net loss of
$43.5 million last year. 2024 Net
loss included financial income of $0.3
million compared to $3.4
million of financial income in 2023. 2024 financial income
resulted from interest deposits and warrants revaluation income
partially offset by bond financing expenses
Adjusted EBITDA in Q4 of 2024, a non-GAAP measurement which
excludes expenses for non-cash share-based compensation and for
non-recurring items, yielded a loss of $9.0
million, compared with a loss of $8.2
million in the fourth quarter of 2023. Adjusted EBITDA for
the full year of 2024 amounted to a $33.3
million loss, a slight decrease from the $32.5 million loss in 2023. We believe that this
non-GAAP measurement is important in management's evaluation of our
use of cash and in planning and evaluating our cash requirements
for the coming period.
Balance Sheet and Liquidity
As of December 31, 2024, Arbe had
$24.6 million in cash and cash
equivalents and in short term bank deposits. In January 2025, we further bolstered our balance
sheet with gross proceeds of $54.5
million, which includes $33
million gross from an underwritten registered direct public
offering and $21.5 million from the
release of escrowed funds following the conversion of a portion of
our outstanding convertible bonds.
Outlook
Arbe's leading radar technology remains a top priority for key
decision-makers in the automotive industry. Recent cash infusions
totaling nearly $70 million further
underscore investor confidence in Arbe's market potential and
growth trajectory.
- While broader economic shifts have led to short-term delays
in automakers' roll-out of advanced driver assistance systems,
decision timelines have been extended. As a result, Arbe continues
to engage closely with industry leaders, advancing through RFQ
stages and reinforced its position for adoption. We continue with
our goal to pursue four design-ins with automakers in 2025.
- 2025 annual revenues are expected to be in the range of
$2 million to $5 million and will be weighted towards the end
of the year.
- We significantly strengthen our balance sheet, and adjusted
EBITDA for 2025 is projected to be in the range of ($29 million) and ($35
million).
Conference Call & Webcast Details
Arbe will host a conference call and webcast today, March 5, 2025, at 8:30 am
ET. Speakers will include Kobi
Marenko, Chief Executive Officer, Co-Founder and Director,
and Karine Pinto-Flomenboim, Chief Financial Officer. We encourage
participants to pre-register for the conference call here.
Callers will receive a unique dial-in upon registration, which
enables immediate access to the call. Participants may pre-register
at any time, including up to and after the call start time.
The live call may be accessed via:
U.S. Toll Free: 1-(844)
481-3015
International: 1-(412)
317-1880
Israel Toll Free: 1-809-212-373
A telephonic replay of the conference call will be available
until March 19, 2025, following the
end of the conference call. To listen to the replay, please
dial:
U.S. Toll Free: 1-(877)
344-7529
International: 1-(412)
317-0088
Access ID: 3040322
A live webcast of the call can be accessed here or
from Arbe's Investor Relations website
at https://ir.arberobotics.com/news/ir-calendar. An archived
webcast of the conference call will also be made available on the
website following the call.
About Arbe
Arbe (Nasdaq: ARBE), a global leader in Perception Radar
Solutions, is spearheading a radar revolution, enabling truly safe
driver-assist systems today while paving the way to full
autonomous-driving. Arbe's radar technology is 100 times more
detailed than any other radar on the market and is a critical
sensor for L2+ and higher autonomy. The company is empowering
automakers, Tier-1 suppliers, autonomous ground vehicles,
commercial and industrial vehicles, and a wide array of safety
applications with advanced sensing and paradigm changing
perception. Arbe, a leader in the fast-growing automotive radar
market, is based in Tel Aviv,
Israel, and has offices in China, Germany, and the
United States.
Cautionary Note Regarding Forward-Looking Statements
This press release contains, and the conference call described
in this press release will contain "forward-looking statements"
within the meaning of the Securities Act of 1933 and the Securities
Exchange Act of 1934, both as amended by the Private Securities
Litigation Reform Act of 1995. The words "expect," "believe,"
"estimate," "intend," "plan," "anticipate," "may," "should,"
"strategy," "future," "will," "project," "potential" and similar
expressions indicate forward-looking statements. Forward-looking
statements are predictions, projections and other statements about
future events that are based on current expectations and
assumptions and, as a result, are subject to risks and
uncertainties. These risks and uncertainties include the effect on
the Israeli economy generally and on the Company's business
resulting from the terrorism and the hostilities in Israel and with its neighboring countries
including the effects of the continuing war with Hamas in
Gaza and any intensification of
hostilities with others, including Iran and Hezbollah, and the effect of the
call-up of a significant portion of its working population,
including the Company's employees; the effect of any potential
boycott both of Israeli products and business and of stocks in
Israeli companies; the effect of any downgrading of the Israeli
economy and the effect of changes in the exchange rate between the
US dollar and the Israeli shekel; and the risk and uncertainties
described in "Cautionary Note Regarding Forward-Looking
Statements," "Item 3. Key Information – D. Risk Factors" and "Item
5. Operating and Financial Review and Prospects" and in the
Company's Annual Report on Form 20-F for the year ended
December 31, 2023, which was filed
with the Securities and Exchange Commission (the "SEC") on
March 28, 2024, as well as other
documents filed by the Company with the SEC. Accordingly, you are
cautioned not to place undue reliance on these forward-looking
statements. Forward-looking statements relate only to the date they
were made, and the Company does not undertake any obligation to
update forward-looking statements to reflect events or
circumstances after the date they were made except as required by
law or applicable regulation.
Information contained on, or that can be accessed through, the
Company's website or any other website or any social media is
expressly not incorporated by reference into and is not a part of
this press release.
Information contained on, or that can be accessed through, our
website or any other website or any social media is expressly not
incorporated by reference into and is not a part of this press
release.
Logo:
https://mma.prnewswire.com/media/803813/Arbe_Robotics_Logo.jpg
|
|
|
|
|
|
CONSOLIDATED BALANCE
SHEETS
|
|
(U.S. dollars in
thousands)
|
|
|
|
|
|
|
|
December 31,
2024
|
|
December 31,
2023
|
|
Current
Assets:
|
|
(Unaudited)
|
|
(Unaudited)
|
|
Cash and cash
equivalents
|
|
13,488
|
|
28,587
|
|
Restricted
cash
|
|
280
|
|
163
|
|
Short term bank
deposits
|
|
10,793
|
|
15,402
|
|
Trade
receivable
|
|
153
|
|
1,258
|
|
Other assets – funds
held in escrow
|
|
30,417
|
|
-
|
|
Prepaid expenses and
other receivables
|
|
2,500
|
|
2,026
|
|
Total current
assets
|
|
57,631
|
|
47,436
|
|
|
|
|
|
|
|
Non-Current
Assets
|
|
|
|
|
|
Operating lease
right-of-use assets
|
|
1,782
|
|
1,740
|
|
Property and equipment,
net
|
|
1,374
|
|
1,309
|
|
Total non-current
assets
|
|
3,156
|
|
3,049
|
|
|
|
|
|
|
|
Total
assets
|
|
60,787
|
|
50,485
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
Trade
payables
|
|
624
|
|
1,149
|
|
Operating lease
liabilities
|
|
551
|
|
436
|
|
Employees and payroll
accruals
|
|
3,283
|
|
2,916
|
|
Convertible
bonds
|
|
30,614
|
|
-
|
|
Accrued expenses and
other payables
|
|
1,334
|
|
1,710
|
|
Total current
liabilities
|
|
36,406
|
|
6,211
|
|
|
|
|
|
|
|
Long term liabilities
|
|
|
|
|
|
Operating lease
liabilities
|
|
1,457
|
|
1,306
|
|
Warrant
liabilities
|
|
428
|
|
875
|
|
Total long-term
liabilities
|
|
1,885
|
|
2,181
|
|
|
|
|
|
|
|
SHAREHOLDERS' EQUITY:
|
|
|
|
|
|
Ordinary
Shares
|
|
*)
|
|
*)
|
|
Additional paid-in
capital
|
|
275,453
|
|
245,733
|
|
Accumulated
Deficit
|
|
(252,957)
|
|
(203,640)
|
|
Total shareholders'
equity
|
|
22,496
|
|
42,093
|
|
|
|
|
|
|
|
Total liabilities
and shareholders' equity
|
|
60,787
|
|
50,485
|
|
|
|
|
|
|
|
*) Represents less than
$1.
|
|
|
|
|
|
CONSOLIDATED
STATEMENTS OF OPERATIONS
|
(U.S. dollars in thousands, except share and per
share data)
|
|
|
|
3 Months Ended
December 31, 2024
|
|
3 Months Ended
December 31, 2023
|
|
12 Months Ended
December 31, 2024
|
|
12 Months Ended
December 31, 2023
|
|
|
(Unaudited)
|
|
(Unaudited)
|
|
(Unaudited)
|
|
(Unaudited)
|
Revenues
|
|
99
|
|
347
|
|
768
|
|
1,470
|
Cost of
revenues
|
|
308
|
|
536
|
|
1,553
|
|
1,508
|
Gross loss
|
|
(209)
|
|
(189)
|
|
(785)
|
|
(38)
|
|
|
|
|
|
|
|
|
|
Operating
Expenses:
|
|
|
|
|
|
|
|
|
Research and
development, net
|
|
9,019
|
|
8,446
|
|
35,091
|
|
34,082
|
Sales and
marketing
|
|
1,187
|
|
1,528
|
|
5,430
|
|
5,194
|
General and
administrative
|
|
2,420
|
|
1,934
|
|
8,347
|
|
7,571
|
Total operating expenses
|
|
12,626
|
|
11,908
|
|
48,868
|
|
46,847
|
|
|
|
|
|
|
|
|
|
Operating loss
|
|
(12,835)
|
|
(12,097)
|
|
(49,653)
|
|
(46,885)
|
|
|
|
|
|
|
|
|
|
Financial income,
net
|
|
(639)
|
|
(2,812)
|
|
(336)
|
|
(3,385)
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
(12,196)
|
|
(9,285)
|
|
(49,317)
|
|
(43,500)
|
|
|
|
|
|
|
|
|
|
Basic net loss per
ordinary share
|
|
(0.15)
|
|
(0.12)
|
|
(0.61)
|
|
(0.60)
|
|
|
|
|
|
|
|
|
|
Weighted-average number
of
ordinary shares used in computing
basic net loss per ordinary share
|
|
81,946,370
|
|
77,837,624
|
|
80,949,032
|
|
72,021,520
|
|
|
|
|
|
|
|
|
|
Diluted net loss per
ordinary share
|
|
(0.15)
|
|
(0.12)
|
|
(0.61)
|
|
(0.61)
|
|
|
|
|
|
|
|
|
|
Weighted-average number
of
ordinary shares used in computing
diluted net loss per ordinary share
|
|
81,946,370
|
|
77,837,624
|
|
80,949,032
|
|
72,053,372
|
|
|
|
|
|
|
|
|
|
|
|
|
CONSOLIDATED STATEMENTS OF CASH
FLOWS
|
|
|
(U.S. dollars in thousands)
|
|
|
|
|
3 Months
Ended
|
|
3 Months
Ended
|
|
12 Months
Ended
|
|
12 Months
Ended
|
|
-
|
|
|
December 31,
2024
|
|
December 31,
2023
|
|
December 31,
2024
|
|
December 31,
2023
|
|
Cash flows from operating
activities:
|
|
(Unaudited)
|
|
(Unaudited)
|
|
(Unaudited)
|
|
(Unaudited)
|
|
Net
Loss
|
|
(12,196)
|
|
(9,285)
|
|
(49,317)
|
|
(43,500)
|
|
Adjustments to
reconcile loss to net cash used in operating activities:
|
|
|
|
|
|
|
|
|
|
Depreciation
|
|
148
|
|
142
|
|
585
|
|
557
|
|
Share-based
compensation
|
|
3,143
|
|
3,584
|
|
14,542
|
|
13,012
|
|
Warrants to service
providers
|
|
547
|
|
197
|
|
1,186
|
|
629
|
|
Revaluation of
warrants
|
|
(112)
|
|
(266)
|
|
(447)
|
|
(756)
|
|
|
Revaluation of
convertible bonds
|
|
(221)
|
|
-
|
|
(81)
|
|
-
|
|
|
Issuance costs related
to convertible bonds
|
|
-
|
|
-
|
|
737
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in operating
assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
Decrease in trade
receivable
|
|
465
|
|
508
|
|
1,105
|
|
694
|
|
|
Increase in prepaid
expenses and other receivables
|
|
(386)
|
|
(749)
|
|
(474)
|
|
(187)
|
|
|
Operating lease ROU
assets and liabilities, net
|
|
59
|
|
90
|
|
224
|
|
86
|
|
|
Increase (decrease) in
trade payables
|
|
(346)
|
|
549
|
|
(553)
|
|
(103)
|
|
|
Increase in employees
and payroll accruals
|
|
187
|
|
396
|
|
367
|
|
55
|
|
|
Increase (decrease) in
accrued expenses and other payables
|
|
463
|
|
(110)
|
|
(376)
|
|
(3,899)
|
|
|
Decrease in deferred
revenue
|
|
-
|
|
(101)
|
|
-
|
|
(101)
|
|
|
|
|
|
Net cash used in
operating activities
|
|
(8,249)
|
|
(5,045)
|
|
(32,502)
|
|
(33,513)
|
|
|
Cash flows from investing
activities:
|
|
|
|
|
|
|
|
|
|
|
Change in bank
deposits
|
|
(10,773)
|
|
10,213
|
|
4,609
|
|
(15,002)
|
|
Purchase of property
and equipment
|
|
(65)
|
|
(59)
|
|
(622)
|
|
(249)
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by
(used in) investing activities
|
|
(10,838)
|
|
10,154
|
|
3,987
|
|
(15,251)
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing
activities:
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance
of ordinary shares, net of issuance costs
|
|
13,787
|
|
-
|
|
13,787
|
|
22,496
|
|
Issuance costs related
to convertible bonds
|
|
-
|
|
-
|
|
(459)
|
|
-
|
|
Proceeds from exercise
of options
|
|
-
|
|
-
|
|
205
|
|
703
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by
financing activities
|
|
13,787
|
|
-
|
|
13,533
|
|
23,199
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate
fluctuations on cash and cash equivalent
|
|
(190)
|
|
768
|
|
258
|
|
47
|
|
|
|
|
|
|
|
|
|
|
|
Increase (decrease) in
cash, cash equivalents and restricted cash
|
|
(5,110)
|
|
4,341
|
|
(15,240)
|
|
(25,612)
|
|
Cash, cash equivalents
and restricted cash at the beginning of period
|
|
19,068
|
|
23,641
|
|
28,750
|
|
54,315
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents and restricted cash at the end
of period
|
|
13,768
|
|
28,750
|
|
13,768
|
|
28,750
|
|
RECONCILIATION OF
GAAP NET LOSS TO NON-GAAP NET LOSS
|
(U.S. dollars in
thousands, except share and per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 Months
Ended
|
|
3 Months
Ended
|
|
12 Months
Ended
|
|
12 Months
Ended
|
|
|
December 31,
2024
|
|
December 31,
2023
|
|
December 31,
2024
|
|
December 31,
2023
|
GAAP net loss
attributable to ordinary shareholders
|
|
(12,196)
|
|
(9,285)
|
|
(49,317)
|
|
(43,500)
|
|
|
|
|
|
|
|
|
|
Add:
|
|
|
|
|
|
|
|
|
Stock-based
compensation
|
|
3,143
|
|
3,584
|
|
14,542
|
|
13,012
|
Warrants to service
providers
|
|
547
|
|
197
|
|
1,186
|
|
629
|
Revaluation of warrants
and accretion
|
|
(112)
|
|
(266)
|
|
(447)
|
|
(756)
|
Convertible bonds
accretion
|
|
(221)
|
|
-
|
|
(81)
|
|
-
|
Non-recurring expenses
related to convertible bonds and ATM
|
|
-
|
|
|
|
805
|
|
214
|
|
|
|
|
|
|
|
|
|
Non-GAAP net
loss
|
|
(8,839)
|
|
(5,770)
|
|
(33,312)
|
|
(30,401)
|
|
|
|
|
|
|
|
|
|
Basic Non-GAAP net loss
per ordinary share
|
|
(0.11)
|
|
(0.07)
|
|
(0.41)
|
|
(0.42)
|
|
|
|
|
|
|
|
|
|
Weighted-average number
of shares used in computing basic Non-
GAAP net loss per ordinary share
|
|
81,946,370
|
|
77,837,624
|
|
80,949,032
|
|
72,021,520
|
|
|
|
|
|
|
|
|
|
Diluted Non-GAAP net
loss per ordinary share
|
|
(0.11)
|
|
(0.07)
|
|
(0.41)
|
|
(0.42)
|
|
|
|
|
|
|
|
|
|
Weighted-average number
of shares used in computing diluted
Non-GAAP net loss per ordinary share
|
|
81,946,370
|
|
77,837,624
|
|
80,949,032
|
|
72,053,372
|
|
|
|
|
|
|
|
|
|
RECONCILIATION OF
GAAP NET LOSS TO ADJUSTED EBITDA
|
(U.S. dollars in
thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 Months
Ended
|
|
3 Months
Ended
|
|
12 Months
Ended
|
|
12 Months
Ended
|
|
|
December 31,
2024
|
|
December 31,
2023
|
|
December 31,
2024
|
|
December 31,
2023
|
GAAP net loss
attributable to ordinary shareholders
|
|
(12,196)
|
|
(9,285)
|
|
(49,317)
|
|
(43,500)
|
|
|
|
|
|
|
|
|
|
Add:
|
|
|
|
|
|
|
|
|
Financial income,
net
|
|
(639)
|
|
(2,812)
|
|
(336)
|
|
(3,385)
|
Depreciation
|
|
148
|
|
142
|
|
585
|
|
557
|
Stock-based
compensation
|
|
3,143
|
|
3,584
|
|
14,542
|
|
13,012
|
Warrants to service
providers
|
|
547
|
|
197
|
|
1,186
|
|
629
|
Non-recurring expenses
related to ATM
|
|
-
|
|
-
|
|
68
|
|
214
|
|
|
|
|
|
|
|
|
|
Adjusted
EBITDA
|
|
(8,997)
|
|
(8,174)
|
|
(33,272)
|
|
(32,473)
|
|
|
|
|
|
|
|
|
|
View original
content:https://www.prnewswire.com/news-releases/arbe-announces-q4-and-full-year-2024-financial-results-302393009.html
SOURCE Arbe